Your browser doesn't support javascript.
loading
Performance of BRCA1/2 mutation prediction models in male breast cancer patients.
Moghadasi, S; Grundeken, V; Janssen, L A M; Dijkstra, N H; Rodríguez-Girondo, M; van Zelst-Stams, W A G; Oosterwijk, J C; Ausems, M G E M; Oldenburg, R A; Adank, M A; Blom, E W; Ruijs, M W G; van Os, T A M; van Deurzen, C H M; Martens, J W M; Schroder, C P; Wijnen, J T; Vreeswijk, M P G; van Asperen, C J.
Afiliação
  • Moghadasi S; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.
  • Grundeken V; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.
  • Janssen LAM; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.
  • Dijkstra NH; Dutch Breast Cancer Research Group, Amsterdam, the Netherlands.
  • Rodríguez-Girondo M; Department of Medical Statistics and Bioinformatics, Leiden University Medical Centre, Leiden, the Netherlands.
  • van Zelst-Stams WAG; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Oosterwijk JC; Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Ausems MGEM; Department of Genetics, University Medical Centre, Utrecht, the Netherlands.
  • Oldenburg RA; Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Adank MA; Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands.
  • Blom EW; Department Clinical Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Ruijs MWG; Department of Clinical Genetics, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Os TAM; Department of Clinical Genetics, Academic Medical Centre, Amsterdam, the Netherlands.
  • van Deurzen CHM; Department of Pathology, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Martens JWM; Department of Medical Oncology, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Schroder CP; Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Wijnen JT; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.
  • Vreeswijk MPG; Department of Human Genetics, Leiden University Medical Centre, Leiden, the Netherlands.
  • van Asperen CJ; Department of Human Genetics, Leiden University Medical Centre, Leiden, the Netherlands.
Clin Genet ; 93(1): 52-59, 2018 Jan.
Article em En | MEDLINE | ID: mdl-28589637
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes Genéticos / Neoplasias da Mama Masculina / Proteína BRCA1 / Predisposição Genética para Doença / Proteína BRCA2 / Mutação Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Genet Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes Genéticos / Neoplasias da Mama Masculina / Proteína BRCA1 / Predisposição Genética para Doença / Proteína BRCA2 / Mutação Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Genet Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda